These success, along with a preceding report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 aid the concept of targeting ACKR3 as a unique strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders. Chronic ache is complex, and https://angelinar159ojj8.snack-blog.com/profile